ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 121 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,345,000 | -35.2% | 180,166 | -20.2% | 0.54% | -16.3% |
| Q2 2019 | $5,162,000 | +7.4% | 225,637 | -1.3% | 0.64% | +0.2% |
| Q1 2019 | $4,806,000 | +18.9% | 228,663 | -35.0% | 0.64% | +11.7% |
| Q4 2018 | $4,042,000 | -71.0% | 351,529 | -42.1% | 0.58% | -64.4% |
| Q3 2018 | $13,932,000 | +2.1% | 607,067 | -0.8% | 1.62% | -7.3% |
| Q2 2018 | $13,649,000 | +12.3% | 612,106 | +15.1% | 1.74% | +7.5% |
| Q1 2018 | $12,150,000 | -29.7% | 531,737 | -19.4% | 1.62% | -24.5% |
| Q4 2017 | $17,292,000 | +52.3% | 660,020 | +30.5% | 2.15% | +57.8% |
| Q3 2017 | $11,351,000 | -20.8% | 505,633 | -3.5% | 1.36% | -0.9% |
| Q2 2017 | $14,335,000 | +75.6% | 524,161 | +55.3% | 1.37% | +98.6% |
| Q1 2017 | $8,165,000 | -15.9% | 337,409 | -27.9% | 0.69% | +16.5% |
| Q4 2016 | $9,705,000 | -18.7% | 467,759 | +6.8% | 0.59% | +8.4% |
| Q3 2016 | $11,936,000 | – | 437,885 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,067,560 | $53,364,000 | 28.19% |
| Selkirk Management LLC | 208,000 | $5,368,000 | 2.94% |
| Iguana Healthcare Management, LLC | 270,000 | $6,969,000 | 2.20% |
| Opaleye Management Inc. | 100,600 | $2,596,000 | 1.03% |
| Miura Global Management | 600,000 | $15,486,000 | 0.94% |
| DSC Advisors, L.P. | 57,400 | $1,481,000 | 0.77% |
| Cannell & Co. | 1,016,828 | $26,244,000 | 0.74% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $7,138,000 | 0.61% |
| Harvest Capital Strategies LLC | 100,000 | $2,581,000 | 0.33% |
| Raging Capital Management, LLC | 93,932 | $2,424,000 | 0.31% |